Success Metrics

Active Trials
7(100%)

Phase Distribution

Ph phase_2
5
71%
Ph not_applicable
1
14%

Phase Distribution

0

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
5(83.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

7

all time

Status Distribution
Active(7)

Detailed Status

Active, not recruiting4
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
7
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 25 (83.3%)
N/A1 (16.7%)

Trials by Status

recruiting343%
active_not_recruiting457%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7